AMENDMENT TO CONVERTIBLE LOAN AGREEMENTS
Exhibit 10.1
AMENDMENT TO CONVERTIBLE LOAN AGREEMENTS
This Amendment to Convertible Loan Agreements (this “Amendment”) dated this 4th day of March, 2019, by and among Wize Pharma Ltd. Private Company 520033259 (the “Company”), Wize Pharma, Inc., Rimon Gold Assets Ltd., Private Company, 514819424 (“Rimon Gold’’), Ridge Valley Corporation (“Ridge Valley”), and Xxxxxxxx Xxxxxx (“Xxxxxx”).
W I T N E S S E T H:
WHEREAS, the Company is party to a convertible loan agreement with Rimon Gold, dated March 20, 2016 (as amended, the “First Convertible Loan Agreement”), as amended by (i) the addendum dated March 30, 2016, between the Company and Rimon Gold, (ii) the second convertible loan agreement (as amended, the “Second Convertible Loan Agreement”) , dated January 12, 2017, among the Company, Rimon Gold, and Ridge Valley, (iii) an amendment to the First Convertible Loan Agreement, dated December 21, 2017, and (iv) an amendment to convertible loan agreements, dated October 19, 2018;
WHEREAS, pursuant to an assignment and assumption, Xxxxxx is party to the Second Convertible Loan Agreement;
WHEREAS, the parties desire to amend the First Convertible Loan Agreement and the Second Convertible Loan Agreement as more particularly set forth below;
WHEREFORE, the parties do hereby agree as follows:
1. This Amendment will be effective immediately.
2. The maturity date (the “Maturity Date”) of the loans under each of the First Convertible Loan Agreement and the Second Convertible Loan Agreement is hereby amended and extended to be May 31, 2019.
3. The expiration date of the investment right under the First Convertible Loan Agreement and the investment option under the Second Convertible Loan Agreement is hereby amended and extended to be 180 days after the Maturity Date (for the sake of clarity, as amended hereby, i.e., to expire on November 30, 2019).
4. Except as modified herein, the terms of the First Convertible Loan Agreement and the Second Convertible Loan Agreement shall remain in full force and effect.
5. This Amendment may be executed in any number of counterparts, each of which when so executed shall be deemed to be an original and shall be binding upon all parties, their successors and assigns, and all of which taken together shall constitute one and the same Amendment. A signature delivered by facsimile shall constitute an original.
[Signature Page Follows]
IN WITNESS WHEREOF, the parties have executed this Amendment as of the date first written above.
| WIZE PHARMA LTD. PRIVATE COMPANY 520033259 | WIZE PHARMA, INC. | |||
| By: | /s/ Or Xxxxxxxxx | By: | /s/ Or Xxxxxxxxx | |
| Name: | Or Xxxxxxxxx | Name: | Or Xxxxxxxxx | |
| Title: | CFO & Acting CEO | Title: | CFO & Acting CEO | |
| RIMON GOLD ASSETS LTD. | ||||
| By: | /s/ Xxxx Xxxxx | |||
| Name: | Xxxx Xxxxx | |||
| Title: | ||||
| RIDGE VALLEY CORPORATION | ||||
| By: | /s/ XXXXXXXXX XXXXX | 28/2/2019 | ||
| Name: | XXXXXXXXX XXXXX | |||
| Title: | DIRECTOR | |||
| /s/ Xxxxxxxx Xxxxxx | ||||
| Xxxxxxxx Xxxxxx | ||||
